Axsome Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/07/2025 | 4.18 M | $507.74 M | 5.97% | 8.46% |
| BLACKROCK, INC. | 11/12/2025 | 3.79 M | $460.41 M | -1.15% | 7.67% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 1.33 M | $162.08 M | 84.07% | 2.70% |
| RTW INVESTMENTS, LP | 11/14/2025 | 1.12 M | $135.89 M | -26.24% | 2.26% |
| MACQUARIE GROUP LTD | 11/13/2025 | 1.08 M | $131.72 M | -4.68% | 2.19% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.04 M | $126.00 M | 69.31% | 2.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 997.70 K | $121.19 M | 0.83% | 2.02% |
| INVESCO LTD. | 11/13/2025 | 990.56 K | $120.30 M | 73.31% | 2.00% |
| STATE STREET CORP | 11/14/2025 | 942.96 K | $114.52 M | -1.62% | 1.91% |
| FMR LLC | 11/13/2025 | 927.88 K | $112.69 M | -5.00% | 1.88% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 900.00 K | $109.31 M | 12.31% | 1.82% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2025 | 815.18 K | $99.00 M | 0.00% | 1.65% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 746.40 K | $90.64 M | 2.86% | 1.51% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 670.88 K | $81.48 M | 0.53% | 1.36% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 531.80 K | $64.59 M | 24.28% | 1.08% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 530.33 K | $64.41 M | 9.78% | 1.07% |
| BVF INC/IL | 11/14/2025 | 486.76 K | $59.12 M | -71.20% | 0.98% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 445.00 K | $54.05 M | -0.45% | 0.90% |
| MORGAN STANLEY | 11/14/2025 | 409.58 K | $49.74 M | -8.56% | 0.83% |
| NORTHERN TRUST CORP | 11/14/2025 | 409.54 K | $49.74 M | 0.03% | 0.83% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 393.50 K | $47.79 M | 320.36% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 382.05 K | $46.40 M | 7.12% | 0.77% |
| MARSHALL WACE, LLP | 11/13/2025 | 378.02 K | $45.91 M | 566.52% | 0.76% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 368.43 K | $44.75 M | 3.64% | 0.75% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 362.14 K | $43.98 M | -12.07% | 0.73% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 361.26 K | $43.88 M | -52.05% | 0.73% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2025 | 359.96 K | $43.72 M | -3.00% | 0.73% |
| WOODLINE PARTNERS LP | 11/14/2025 | 331.86 K | $40.30 M | 0.22% | 0.67% |
| LOOMIS SAYLES & CO L P | 11/13/2025 | 330.13 K | $40.09 M | 18.98% | 0.67% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 11/12/2025 | 326.32 K | $39.63 M | 0.00% | 0.66% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 325.63 K | $39.55 M | -16.85% | 0.66% |
| NUVEEN, LLC | 11/12/2025 | 298.34 K | $36.23 M | 5.43% | 0.60% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 296.29 K | $35.98 M | 47.58% | 0.60% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 294.77 K | $35.80 M | 62.89% | 0.60% |
| TRI LOCUM PARTNERS LP | 11/14/2025 | 292.14 K | $35.48 M | 85.06% | 0.59% |
| MAN GROUP PLC | 11/14/2025 | 287.91 K | $34.97 M | -45.17% | 0.58% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 285.60 K | $34.69 M | 2.55% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 285.00 K | $34.61 M | -2.43% | 0.58% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 274.01 K | $33.28 M | 10.17% | 0.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 273.20 K | $33.18 M | 53.22% | 0.55% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 253.26 K | $30.76 M | 24.37% | 0.51% |
| JPMORGAN CHASE & CO | 11/26/2025 | 250.51 K | $30.42 M | 33.44% | 0.51% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 224.14 K | $27.22 M | -1.78% | 0.45% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 223.41 K | $27.13 M | 0.06% | 0.45% |
| UBS GROUP AG | 11/13/2025 | 212.45 K | $25.80 M | -64.32% | 0.43% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 209.07 K | $25.39 M | -6.97% | 0.42% |
| B. RILEY WEALTH ADVISORS, INC. | 10/31/2025 | 200.00 K | $242.90 K | 100.00% | 0.40% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 197.32 K | $23.96 M | 7.14% | 0.40% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 190.11 K | $23.09 M | 1.97% | 0.38% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2025 | 172.80 K | $20.99 M | 90.31% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Axsome Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 460 institutional investors and hedge funds held shares of Axsome Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 4.18 M
BlackRock, Inc.: 3.79 M
WELLINGTON MANAGEMENT GROUP LLP: 1.33 M
RTW INVESTMENTS, LP: 1.12 M
MACQUARIE GROUP LTD: 1.08 M
PRICE T ROWE ASSOCIATES INC /MD/: 1.04 M
75.20% of Axsome Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 46.34 M shares in the last 24 months. This purchase volume represents approximately $6.86 B in transactions.